News: TLX Telix Pharmaceuticals Aims Up To $4.17 Bln Valuation In US IPO, page-3

by my calculations ...

pls correct me if im wrong

US$200m / 17m shares = US$ 11.76/ .6644

equals AUD $ 17.70

a stone throw from all-time highs


YAY (in olden days stock was offered at a discount)


bring on UK. EU Illuccix
bring on TLX 591/592 Illucix 2.0

bring on Tomorrow !!!!





StatesTelix Announces Launch of Proposed Initial Public Offering in the United States MELBOURNE, Australia, June 05, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited(the "Company" or "Telix") today announces the launch of its initial public offering inthe United States (the "Offering") of 17,000,000 American Depositary Shares ("ADSs"),each representing one ordinary share in Telix. The target size of the Offering is US$200million in gross proceeds. In addition, Telix expects to grant the Underwriters (asdefined below) a 30-day option to purchase up to an additional 15% of the number of ADSssold in the Offering at the initial public offering price, less underwriting discountsand commissions. All ADSs to be issued in the Offering will be offered by Telix. Jefferies, Morgan Stanley, Truist Securities and William Blair are acting as jointbook-running managers for the Offering (collectively, the Underwriters). Telix has applied to list its ADSs on the Nasdaq Global Market (Nasdaq) under theticker symbol "TLX". Telix's ordinary shares are listed, and upon the completing of theOffering, will continue to trade on the Australian Securities Exchange (ASX) under thesymbol "TLX". The Offering is being made only by means of a prospectus under the U.S. Securities Actof 1933, as amended. Copies of the preliminary prospectus relating to and describing theterms of the Offering may be obtained, when available, from (i) Jefferies LLC, Attention:Equity Syndicate Prospectus Department, 520 Madison Avenue, New York, NY 10022, or bytelephone at (877) 821-7388, or by email at [email protected]; or (ii)Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, 2nd Floor,New York, NY 10014, or by email at [email protected]; or (iii) TruistSecurities, Inc., Attention: Prospectus Department, 3333 Peachtree Road NE, 9th floor,Atlanta, GA 30326, or by telephone at (800) 685-4786, or by email [email protected]; or (iv) William Blair & Company, L.L.C.,Attention: Prospectus Department, 150 North Riverside Plaza, Chicago, IL 60606, or bytelephone at (800) 621-0687, or by email at [email protected]. Australianinvestors are only eligible to invest under the prospectus if they are exempt fromdisclosure (for example, as sophisticated or professional investors) under theCorporations Act 2001 (Cth). A registration statement relating to the securities referred to herein has been filedwith the Securities and Exchange Commission but has not yet become effective. Thesesecurities may not be sold, nor may offers to buy these securities be accepted, prior tothe time the registration statement becomes effective. This press release does not constitute an offer to sell or the solicitation of an offerto buy securities in any jurisdiction, and shall not constitute an offer, solicitation orsale in any jurisdiction in which such offer, solicitation or sale would be unlawfulprior to registration or qualification under the securities laws of that jurisdiction. Asdisclosed in the registration statement, the Underwriters may purchase and sell ADSs inthe open market, including to cover over-allotments in connection with marketstabilization activities in relation to the Offering.